Our Customers
Products & Pipeline
Science & DTx
For business
About us
Contact us
US Payers

Dr Andrew Welchman

Senior Leadership Team

Andrew is our EVP for Impact. He joined ieso in 2021 to help us harness our scientific breakthroughs and clinical learnings to transform global mental healthcare at scale.

Working alongside our Chief Scientific Officer, Andy Blackwell, he is responsible for forging strategic alliances with a wide range of organisations to collaborate on ground-breaking research and accelerate innovation and the adoption of new breakthroughs.

The significant advances being made in data science at ieso are set to transform the delivery of mental health and Andrew will be instrumental in amplifying our success to date.

As Head of Neuroscience and Mental Health at the Wellcome Trust, Dr Welchman led strategic initiatives for a £500m portfolio in cutting-edge brain science. He developed the multi-million-pound initiative in Mental Health Science that has become central to Wellcome’s ambitions for the next two decades.

As Professor of Neural Intelligence at the University of Cambridge, Andrew and his team combined advanced human brain imaging and AI to uncover how we perceive and understand the world around us. He is a Fellow of the Royal Society of Biology, has worked closely with several Royal Colleges (Royal College of Psychiatry; Royal College of Ophthalmology), and has been an advisor for large-scale international research efforts, collaborative partnerships (The India Alliance), The World Economic Forum and charities (BBC Children in Need).

“We know that poor mental health is an urgent and global problem – but we now need actions to meet the challenge. I have long admired ieso’s innovative data-driven approach to mental healthcare that shows how rigorous science improves treatment quality and delivers results for people suffering from mental health conditions. Tectonic shifts in technology mean we are primed to make quality care available for all. We are determined to drive change to reduce suffering so that millions of people around the globe lead flourishing lives.”

The Board and Leadership Team

Dr Andy Blackwell

Group Chief Science & Strategy Officer

Clare Hurley

Chief Operating Officer (UK)

Danah Tangen

SVP US Market Development

Dr Valentin Tablan

Chief Artificial Intelligence Officer

Dr Charlotte Housden

Interim Chief Product Officer

Dr Andrew Welchman

EVP Impact & Corporate Development

Siobhan Brown Chartered FCIPD

Human Resources Director

Robert Spavin

EVP Legal & IP